Early Breast Feeding and Glucose Levels in High Risk Newborns
NCT ID: NCT00332449
Last Updated: 2008-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2007-06-30
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immediate Skin-To-Skin Contact and Early Breastfeeding During Caesarean Section
NCT06543160
Effect of Paternal Touch on Sucking Performance, Comfort, and Glucose Levels in Newborns at Risk for Hypoglycemia
NCT07302412
Reduced Infant Response to a Routine Care Procedure After Glucose 25% Analgesia in Comparison to Materna RTF Stage 1
NCT01514253
Reduced Infant Response To A Routine Care Procedure After Glucose 25% Analgesia
NCT01289808
Prevention of the Procedural Pain in the Newborn
NCT02109263
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Newborns to hypertensive mothers
* Newborns with birth weight greater than 4 Kg or less than 2.5 Kg
* Newborns with meconium stained amniotic fluid
Exclusion Criteria
* Preterm babies
* Newborns with post-birth distress
1 Day
1 Day
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheba Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sheba Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ayala Maayan-Metzger, MD
Role: PRINCIPAL_INVESTIGATOR
Sheba Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sheba Medical Center - Neonatal Department
Ramat Gan, Tel-Hashomer, Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHEBA-06-4112-AM-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.